If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Offer for Subscription - Update

4 Aug 2021 15:30

RNS Number : 6032H
Amati AIM VCT PLC
04 August 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

Amati AIM VCT plc

4 August 2021

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Offer for subscription - Update

The Board of Amati AIM VCT plc (the "Company") announced on 28 July 2021 that the Company had published a prospectus (the "Prospectus") in connection with proposals to raise up to £40 million (with an over-allotment facility to raise up to a further £25 million), by way of an offer for subscription of new ordinary shares (the "Offer") (the "New Shares").

The Board has been advised that, on the basis of applications received, the Company has successfully raised £40 million under the Offer. The Board does not intend to utilise the over-allotment facility at the current time, but the Investment Manager is closely monitoring potential investment opportunities and, if it is felt appropriate, the Company will seek to raise further funds under the over-allotment facility prior to the Offer closing.

The first allotment of New Shares is expected to be on or around 9 August 2021. Dealings in the New Shares issued under this allotment are expected to become effective on 23 August 2021. The Company is no longer accepting applications in relation to the Offer. Investors whose applications are received after the Company raised £40 million will have their subscription monies returned in accordance with the terms and conditions of the Offer. If the over-allotment facility is to be utilised, the Company will make a further RNS announcement detailing the application process.

For further information, please contact the investor line at Amati Global Investors on 0131 503 9115 or by email at info@amatiglobal.com.

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe for or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUPUBPRUPGGCC
Date   Source Headline
30th Aug 20229:05 amRNSNet Asset Value(s)
22nd Aug 20222:20 pmRNSTransaction in Own Shares
19th Aug 20224:43 pmRNSNet Asset Value(s)
16th Aug 20224:18 pmRNSTransaction in Own Shares
12th Aug 20223:47 pmRNSNet Asset Value(s)
5th Aug 20223:03 pmRNSNet Asset Value(s)
2nd Aug 202210:54 amRNSNet Asset Value(s)
1st Aug 202210:56 amRNSTotal Voting Rights
25th Jul 20222:05 pmRNSDirector/PDMR Shareholding
22nd Jul 20224:25 pmRNSIssue of Equity - DRIS
22nd Jul 20222:46 pmRNSNet Asset Value(s)
15th Jul 20223:53 pmRNSNet Asset Value(s)
13th Jul 202212:53 pmRNSTransaction in Own Shares
8th Jul 20225:24 pmRNSNet Asset Value(s)
4th Jul 20229:57 amRNSNet Asset Value(s)
1st Jul 20221:33 pmRNSTotal Voting Rights
30th Jun 20223:43 pmRNSTransaction in Own Shares
24th Jun 20224:35 pmRNSNet Asset Value(s)
17th Jun 20223:21 pmRNSNet Asset Value(s)
16th Jun 20223:09 pmRNSResult of AGM
13th Jun 20229:45 amRNSTransaction in Own Shares
10th Jun 20221:57 pmRNSNet Asset Value(s)
1st Jun 20223:56 pmRNSNet Asset Value(s)
1st Jun 20229:27 amRNSTotal Voting Rights
27th May 20223:45 pmRNSNet Asset Value(s)
26th May 20227:00 amRNSTransaction in Own Shares
20th May 20224:06 pmRNSNet Asset Value(s)
19th May 20223:23 pmRNSTransaction in Own Shares
13th May 20223:36 pmRNSNet Asset Value(s)
12th May 20224:57 pmRNSTransaction in Own Shares
11th May 20227:00 amRNSTransaction in Own Shares
9th May 20227:00 amRNSNet Asset Value(s)
5th May 20221:24 pmRNSTransaction in Own Shares
4th May 202212:24 pmRNSTransaction in Own Shares
3rd May 20225:10 pmRNSNet Asset Value(s)
3rd May 20224:09 pmRNSTotal Voting Rights
28th Apr 20224:50 pmRNSTransaction in Own Shares
25th Apr 20222:19 pmRNSTransaction in Own Shares
22nd Apr 20225:03 pmRNSNet Asset Value(s)
13th Apr 20224:58 pmRNSDirector/PDMR Shareholding
13th Apr 20224:56 pmRNSIssue of Equity
13th Apr 20227:01 amRNSDividend Declaration
13th Apr 20227:00 amRNSAnnual Financial Report
12th Apr 20222:34 pmRNSNet Asset Value(s)
8th Apr 20224:37 pmRNSNet Asset Value(s)
1st Apr 20224:18 pmRNSNet Asset Value(s)
1st Apr 202211:02 amRNSTotal Voting Rights
25th Mar 20223:16 pmRNSNet Asset Value(s)
18th Mar 20225:25 pmRNSNet Asset Value(s)
14th Mar 20221:48 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.